HEADER OXIDOREDUCTASE 04-JUN-02 1LX6 TITLE CRYSTAL STRUCTURE OF E. COLI ENOYL REDUCTASE-NAD+ WITH A BOUND TITLE 2 BENZAMIDE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADH]; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: NADH-DEPENDENT ENOYL-ACP REDUCTASE; COMPND 5 EC: 1.3.1.9; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 562; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS FABI, ENOYL REDUCTASE, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR W.W.SMITH,X.QIU,C.A.JANSON REVDAT 5 14-FEB-24 1LX6 1 REMARK REVDAT 4 13-JUL-11 1LX6 1 VERSN REVDAT 3 24-FEB-09 1LX6 1 VERSN REVDAT 2 01-APR-03 1LX6 1 JRNL REVDAT 1 04-SEP-02 1LX6 0 JRNL AUTH W.H.MILLER,M.A.SEEFELD,K.A.NEWLANDER,I.N.UZINSKAS, JRNL AUTH 2 W.J.BURGESS,D.A.HEERDING,C.C.YUAN,M.S.HEAD,D.J.PAYNE, JRNL AUTH 3 S.F.RITTENHOUSE,T.D.MOORE,S.C.PEARSON,V.BERRY, JRNL AUTH 4 W.E.DEWOLF JR.,P.M.KELLER,B.J.POLIZZI,X.QIU,C.A.JANSON, JRNL AUTH 5 W.F.HUFFMAN JRNL TITL DISCOVERY OF AMINOPYRIDINE-BASED INHIBITORS OF BACTERIAL JRNL TITL 2 ENOYL-ACP REDUCTASE (FABI). JRNL REF J.MED.CHEM. V. 45 3246 2002 JRNL REFN ISSN 0022-2623 JRNL PMID 12109908 JRNL DOI 10.1021/JM020050+ REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 590722.010 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 86.9 REMARK 3 NUMBER OF REFLECTIONS : 20345 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.188 REMARK 3 FREE R VALUE : 0.250 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 981 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.012 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.50 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 83.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1442 REMARK 3 BIN R VALUE (WORKING SET) : 0.2500 REMARK 3 BIN FREE R VALUE : 0.3400 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 72 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.120 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3598 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 144 REMARK 3 SOLVENT ATOMS : 247 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.46 REMARK 3 ESD FROM SIGMAA (A) : 0.44 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.41 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.41 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.012 REMARK 3 BOND ANGLES (DEGREES) : 1.940 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : 1.450 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : OVERALL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1LX6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-JUN-02. REMARK 100 THE DEPOSITION ID IS D_1000016370. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-FEB-99 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X12C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : SI REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : BRANDEIS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20345 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.0 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : 0.05700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 18.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.44 REMARK 200 COMPLETENESS FOR SHELL (%) : 83.0 REMARK 200 DATA REDUNDANCY IN SHELL : 1.58 REMARK 200 R MERGE FOR SHELL (I) : 0.19800 REMARK 200 R SYM FOR SHELL (I) : 0.19800 REMARK 200 FOR SHELL : 2.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: PDB 1C14 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.93 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.67 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M HEPES, 2M(NH4)2SO4,5% PEG400, PH REMARK 280 7.50, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 7555 Y,X,-Z+1/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+2/3 REMARK 290 10555 -Y,-X,-Z+5/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 109.02667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 218.05333 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 163.54000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 272.56667 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 54.51333 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 109.02667 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 218.05333 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 272.56667 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 163.54000 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 54.51333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 21840 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 28380 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -150.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.500000 -0.866025 0.000000 39.72000 REMARK 350 BIOMT2 2 -0.866025 -0.500000 0.000000 68.79706 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 272.56667 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ARG A 193 REMARK 465 THR A 194 REMARK 465 LEU A 195 REMARK 465 ALA A 196 REMARK 465 ALA A 197 REMARK 465 SER A 198 REMARK 465 GLY A 199 REMARK 465 ILE A 200 REMARK 465 LYS A 201 REMARK 465 ASP A 202 REMARK 465 PHE A 203 REMARK 465 ARG A 204 REMARK 465 LYS A 205 REMARK 465 GLU A 258 REMARK 465 LEU A 259 REMARK 465 GLU A 260 REMARK 465 LEU A 261 REMARK 465 LYS A 262 REMARK 465 MET B 1 REMARK 465 ARG B 193 REMARK 465 THR B 194 REMARK 465 LEU B 195 REMARK 465 ALA B 196 REMARK 465 ALA B 197 REMARK 465 SER B 198 REMARK 465 GLY B 199 REMARK 465 ILE B 200 REMARK 465 LYS B 201 REMARK 465 ASP B 202 REMARK 465 PHE B 203 REMARK 465 ARG B 204 REMARK 465 LYS B 205 REMARK 465 GLU B 258 REMARK 465 LEU B 259 REMARK 465 GLU B 260 REMARK 465 LEU B 261 REMARK 465 LYS B 262 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 63 116.97 -161.63 REMARK 500 ASN A 155 -23.30 69.63 REMARK 500 ASN A 157 -126.40 33.84 REMARK 500 VAL A 247 74.51 -113.82 REMARK 500 ASP B 58 27.34 -140.83 REMARK 500 CYS B 63 114.79 -163.15 REMARK 500 SER B 91 60.68 -118.99 REMARK 500 LEU B 100 43.13 -86.50 REMARK 500 ASN B 155 -23.26 75.30 REMARK 500 ASN B 157 -122.15 32.30 REMARK 500 VAL B 247 70.38 -113.53 REMARK 500 REMARK 500 REMARK: NULL REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 HOH B 594 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZAM A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD B 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZAM B 504 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1C14 RELATED DB: PDB REMARK 900 1C14 IS THE CRYSTAL STRUCTURE OF E COLI ENOYL REDUCTASE-NAD+- REMARK 900 TRICLOSAN COMPLEX REMARK 900 RELATED ID: 1I2Z RELATED DB: PDB REMARK 900 1I2Z IS E. COLI ENOYL REDUCTASE IN COMPLEX WITH NAD AND BRL-12654 REMARK 900 RELATED ID: 1I30 RELATED DB: PDB REMARK 900 1I30 IS E. COLI ENOYL REDUCTASE +NAD+SB385826 REMARK 900 RELATED ID: 1QG6 RELATED DB: PDB REMARK 900 1QG6 IS THE CRYSTAL STRUCTURE OF E. COLI ENOYL ACYL CARRIER PROTEIN REMARK 900 REDUCTASE IN COMPLEX WITH NAD AND TRICLOSAN REMARK 900 RELATED ID: 1LXC RELATED DB: PDB REMARK 900 1LXC IS THE CRYSTAL STRUCTURE OF E. COLI ENOYL REDUCTASE-NAD+ WITH REMARK 900 A BOUND ACRYLAMIDE INHIBITOR DBREF 1LX6 A 1 262 UNP P29132 FABI_ECOLI 0 261 DBREF 1LX6 B 1 262 UNP P29132 FABI_ECOLI 0 261 SEQRES 1 A 262 MET GLY PHE LEU SER GLY LYS ARG ILE LEU VAL THR GLY SEQRES 2 A 262 VAL ALA SER LYS LEU SER ILE ALA TYR GLY ILE ALA GLN SEQRES 3 A 262 ALA MET HIS ARG GLU GLY ALA GLU LEU ALA PHE THR TYR SEQRES 4 A 262 GLN ASN ASP LYS LEU LYS GLY ARG VAL GLU GLU PHE ALA SEQRES 5 A 262 ALA GLN LEU GLY SER ASP ILE VAL LEU GLN CYS ASP VAL SEQRES 6 A 262 ALA GLU ASP ALA SER ILE ASP THR MET PHE ALA GLU LEU SEQRES 7 A 262 GLY LYS VAL TRP PRO LYS PHE ASP GLY PHE VAL HIS SER SEQRES 8 A 262 ILE GLY PHE ALA PRO GLY ASP GLN LEU ASP GLY ASP TYR SEQRES 9 A 262 VAL ASN ALA VAL THR ARG GLU GLY PHE LYS ILE ALA HIS SEQRES 10 A 262 ASP ILE SER SER TYR SER PHE VAL ALA MET ALA LYS ALA SEQRES 11 A 262 CYS ARG SER MET LEU ASN PRO GLY SER ALA LEU LEU THR SEQRES 12 A 262 LEU SER TYR LEU GLY ALA GLU ARG ALA ILE PRO ASN TYR SEQRES 13 A 262 ASN VAL MET GLY LEU ALA LYS ALA SER LEU GLU ALA ASN SEQRES 14 A 262 VAL ARG TYR MET ALA ASN ALA MET GLY PRO GLU GLY VAL SEQRES 15 A 262 ARG VAL ASN ALA ILE SER ALA GLY PRO ILE ARG THR LEU SEQRES 16 A 262 ALA ALA SER GLY ILE LYS ASP PHE ARG LYS MET LEU ALA SEQRES 17 A 262 HIS CYS GLU ALA VAL THR PRO ILE ARG ARG THR VAL THR SEQRES 18 A 262 ILE GLU ASP VAL GLY ASN SER ALA ALA PHE LEU CYS SER SEQRES 19 A 262 ASP LEU SER ALA GLY ILE SER GLY GLU VAL VAL HIS VAL SEQRES 20 A 262 ASP GLY GLY PHE SER ILE ALA ALA MET ASN GLU LEU GLU SEQRES 21 A 262 LEU LYS SEQRES 1 B 262 MET GLY PHE LEU SER GLY LYS ARG ILE LEU VAL THR GLY SEQRES 2 B 262 VAL ALA SER LYS LEU SER ILE ALA TYR GLY ILE ALA GLN SEQRES 3 B 262 ALA MET HIS ARG GLU GLY ALA GLU LEU ALA PHE THR TYR SEQRES 4 B 262 GLN ASN ASP LYS LEU LYS GLY ARG VAL GLU GLU PHE ALA SEQRES 5 B 262 ALA GLN LEU GLY SER ASP ILE VAL LEU GLN CYS ASP VAL SEQRES 6 B 262 ALA GLU ASP ALA SER ILE ASP THR MET PHE ALA GLU LEU SEQRES 7 B 262 GLY LYS VAL TRP PRO LYS PHE ASP GLY PHE VAL HIS SER SEQRES 8 B 262 ILE GLY PHE ALA PRO GLY ASP GLN LEU ASP GLY ASP TYR SEQRES 9 B 262 VAL ASN ALA VAL THR ARG GLU GLY PHE LYS ILE ALA HIS SEQRES 10 B 262 ASP ILE SER SER TYR SER PHE VAL ALA MET ALA LYS ALA SEQRES 11 B 262 CYS ARG SER MET LEU ASN PRO GLY SER ALA LEU LEU THR SEQRES 12 B 262 LEU SER TYR LEU GLY ALA GLU ARG ALA ILE PRO ASN TYR SEQRES 13 B 262 ASN VAL MET GLY LEU ALA LYS ALA SER LEU GLU ALA ASN SEQRES 14 B 262 VAL ARG TYR MET ALA ASN ALA MET GLY PRO GLU GLY VAL SEQRES 15 B 262 ARG VAL ASN ALA ILE SER ALA GLY PRO ILE ARG THR LEU SEQRES 16 B 262 ALA ALA SER GLY ILE LYS ASP PHE ARG LYS MET LEU ALA SEQRES 17 B 262 HIS CYS GLU ALA VAL THR PRO ILE ARG ARG THR VAL THR SEQRES 18 B 262 ILE GLU ASP VAL GLY ASN SER ALA ALA PHE LEU CYS SER SEQRES 19 B 262 ASP LEU SER ALA GLY ILE SER GLY GLU VAL VAL HIS VAL SEQRES 20 B 262 ASP GLY GLY PHE SER ILE ALA ALA MET ASN GLU LEU GLU SEQRES 21 B 262 LEU LYS HET NAD A 501 44 HET ZAM A 502 28 HET NAD B 503 44 HET ZAM B 504 28 HETNAM NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM ZAM 3-[(ACETYL-METHYL-AMINO)-METHYL]-4-AMINO-N-METHYL-N-(1- HETNAM 2 ZAM METHYL-1H-INDOL-2-YLMETHYL)-BENZAMIDE FORMUL 3 NAD 2(C21 H27 N7 O14 P2) FORMUL 4 ZAM 2(C22 H26 N4 O2) FORMUL 7 HOH *247(H2 O) HELIX 1 1 SER A 19 GLU A 31 1 13 HELIX 2 2 ASN A 41 LYS A 43 5 3 HELIX 3 3 LEU A 44 LEU A 55 1 12 HELIX 4 4 GLU A 67 TRP A 82 1 16 HELIX 5 5 PRO A 96 ASP A 101 5 6 HELIX 6 6 ASP A 103 VAL A 108 1 6 HELIX 7 7 THR A 109 SER A 121 1 13 HELIX 8 8 SER A 121 ARG A 132 1 12 HELIX 9 9 TYR A 146 GLU A 150 5 5 HELIX 10 10 VAL A 158 GLY A 178 1 21 HELIX 11 11 MET A 206 THR A 214 1 9 HELIX 12 12 THR A 221 CYS A 233 1 13 HELIX 13 13 SER A 234 ALA A 238 5 5 HELIX 14 14 SER B 19 GLU B 31 1 13 HELIX 15 15 ASN B 41 LEU B 55 1 15 HELIX 16 16 GLU B 67 LYS B 80 1 14 HELIX 17 17 PRO B 96 ASP B 101 5 6 HELIX 18 18 ASP B 103 VAL B 108 1 6 HELIX 19 19 THR B 109 SER B 121 1 13 HELIX 20 20 SER B 121 ARG B 132 1 12 HELIX 21 21 SER B 133 LEU B 135 5 3 HELIX 22 22 TYR B 146 GLU B 150 5 5 HELIX 23 23 ASN B 157 GLY B 178 1 22 HELIX 24 24 MET B 206 THR B 214 1 9 HELIX 25 25 THR B 221 CYS B 233 1 13 HELIX 26 26 SER B 234 ALA B 238 5 5 HELIX 27 27 GLY B 250 ALA B 254 5 5 SHEET 1 A 7 VAL A 60 GLN A 62 0 SHEET 2 A 7 GLU A 34 TYR A 39 1 N PHE A 37 O LEU A 61 SHEET 3 A 7 ARG A 8 VAL A 11 1 N VAL A 11 O ALA A 36 SHEET 4 A 7 PHE A 88 HIS A 90 1 O VAL A 89 N LEU A 10 SHEET 5 A 7 SER A 139 SER A 145 1 O LEU A 142 N HIS A 90 SHEET 6 A 7 VAL A 182 ALA A 189 1 O ILE A 187 N SER A 145 SHEET 7 A 7 VAL A 244 VAL A 247 1 O VAL A 247 N SER A 188 SHEET 1 B 7 VAL B 60 GLN B 62 0 SHEET 2 B 7 GLU B 34 TYR B 39 1 N PHE B 37 O LEU B 61 SHEET 3 B 7 ARG B 8 VAL B 11 1 N VAL B 11 O ALA B 36 SHEET 4 B 7 PHE B 88 HIS B 90 1 O VAL B 89 N LEU B 10 SHEET 5 B 7 SER B 139 SER B 145 1 O LEU B 142 N HIS B 90 SHEET 6 B 7 VAL B 182 ALA B 189 1 O ILE B 187 N SER B 145 SHEET 7 B 7 VAL B 244 VAL B 247 1 O VAL B 245 N SER B 188 SITE 1 AC1 21 GLY A 13 SER A 19 ILE A 20 GLN A 40 SITE 2 AC1 21 CYS A 63 ASP A 64 VAL A 65 SER A 91 SITE 3 AC1 21 ILE A 92 GLY A 93 ILE A 119 LEU A 144 SITE 4 AC1 21 SER A 145 LYS A 163 ALA A 189 GLY A 190 SITE 5 AC1 21 PRO A 191 ILE A 192 ZAM A 502 HOH A 534 SITE 6 AC1 21 HOH A 546 SITE 1 AC2 6 GLY A 93 PHE A 94 TYR A 146 ASN A 155 SITE 2 AC2 6 TYR A 156 NAD A 501 SITE 1 AC3 22 GLY B 13 ALA B 15 SER B 19 ILE B 20 SITE 2 AC3 22 GLN B 40 CYS B 63 ASP B 64 VAL B 65 SITE 3 AC3 22 SER B 91 ILE B 92 ILE B 119 SER B 145 SITE 4 AC3 22 LYS B 163 ALA B 189 GLY B 190 PRO B 191 SITE 5 AC3 22 ILE B 192 ZAM B 504 HOH B 512 HOH B 520 SITE 6 AC3 22 HOH B 522 HOH B 579 SITE 1 AC4 9 GLY B 93 PHE B 94 ALA B 95 TYR B 146 SITE 2 AC4 9 ASN B 155 TYR B 156 MET B 206 NAD B 503 SITE 3 AC4 9 HOH B 520 CRYST1 79.440 79.440 327.080 90.00 90.00 120.00 P 61 2 2 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012590 0.007270 0.000000 0.00000 SCALE2 0.000000 0.014540 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003060 0.00000